NR 565 PHARM MIDTERM QUESTIONS
WITH CORRECT ANSWERS 2025
CYP2D6R-RCORRECTRANSWERR-NeedRtoRincreaseRdosesRofRSSRI,RbetaRblockersRetc.
CodeineRcanRbeRdeadly
CYP2C9R-RCORRECTRANSWERR-DecreaseRwarfarinRdose
TestRforRgeneRVCORC1Rmutation
CYP3A4R-RCORRECTRANSWERR-DecreasesRelimination
IncreaseRtoxicityRofRAmio
ScheduleRIR-RCORRECTRANSWERR-noRacceptedRmedicalRuseRinRtheRUSRitRmayRnotRbeRprescribed.
heroin,variousRopiumRderivatives,hallucinogenicRsubstances
ScheduleRIIR-RCORRECTRANSWERR-NoRrefills,RnoRtelephoneRorders
Narcotics,RStimulants,RDepressants
ScheduleRIIIR-RCORRECTRANSWERR-
DrugsRinRthisRcategoryRareRconsideredRtoRbeRatRmoderateRorRlowRriskRforRphysicalRdependence,RandRwithRc
urrentRreasonsRforRmedicalRuse
AnabolicRsteroids,RmostRbarbituatesRandRketamine
MustRprescribeReveryR6Rmonths,RcanRbeRbyRphone
ScheduleRIVR-RCORRECTRANSWERR-
AbuseRpotentialRexists,RbutRlessRthanRSchRIII.RExamplesRare:RAmbien,RDarvocetRandRLorazepam
ScheduleRVR-RCORRECTRANSWERR-NotRalwaysRnecessaryRtoRhaveRaRprescription
Loperamide,RdiphenoxylateRandRcoughRmedicineRwithRlessRthanR200mg/100RmlRpregabalin
, PreclinicalRresearchR-RCORRECTRANSWERR-
ResearchRofRdrugRpotential,RanimalRtesting,RpreparationRforRhumanRtesting
PhaseRIR-RCORRECTRANSWERR-
InitialRclinicalRsafetyRstudiesRinRhumans.RMayRbeRasRfewRasR10Rsubjects,RoftenRhealthyRvolunteers
PhaseRIIR-RCORRECTRANSWERR-TheRstudyRdrugRorRtreatmentRisRgivenRtoRaRlargerRgroupRofRpeopleR(100-
300)RtoRseeRifRitRisReffectiveRandRtoRfurtherRevaluateRitsRsafety
PhaseRIIIR-RCORRECTRANSWERR-TheRstudyRdrugRorRtreatmentRisRgivenRtoRlargeRgroupsRofRpeopleR(1,000-
3,000)RtoRconfirmRitsReffectiveness,RmonitorRsideReffects,RcompareRitRtoRcommonlyRusedRtreatments,RandRc
ollectRinformationRthatRwillRallowRtheRdrugRorRtreatmentRtoRbeRusedRsafely
PhaseRIVR-RCORRECTRANSWERR-
ARstudyRconductedRafterRaRdrugRhasRbeenRshownRtoRworkRandRhasRbeenRgrantedRaRlicenseR(post-
marketingRsurveillanceRstudy)
AdrenergicRagonistsR-RCORRECTRANSWERR-
DrugsRthatRstimulateRandRmimicRtheRactionsRofRtheRsympatheticRnervousRsystem.RAlsoRcalledRsympathomi
metics.
alphaR2RagonistsR-RCORRECTRANSWERR-
DecreaseRsympatheticRimpulsesRfromRtheRCNSRtoRtheRheartRandRarterioles,RcausingRvasodilation
LowersRbloodRpressure,RdiureticRmayRbeRneeded
Clonodine,RMethyldopa,RGuanabenz
SE:RdryRmouth,RurinaryRretention,RweightRgainRetc.
AdrenergicRAntagonistR-RCORRECTRANSWERR-
ARdrugRthatRblocksRtheRactionsRofRtheRsympatheticRnervousRsystem.
AlphaR1RAntagonistR-RCORRECTRANSWERR-DecreasesRarterialRandRvenousRvasoconstriction
WITH CORRECT ANSWERS 2025
CYP2D6R-RCORRECTRANSWERR-NeedRtoRincreaseRdosesRofRSSRI,RbetaRblockersRetc.
CodeineRcanRbeRdeadly
CYP2C9R-RCORRECTRANSWERR-DecreaseRwarfarinRdose
TestRforRgeneRVCORC1Rmutation
CYP3A4R-RCORRECTRANSWERR-DecreasesRelimination
IncreaseRtoxicityRofRAmio
ScheduleRIR-RCORRECTRANSWERR-noRacceptedRmedicalRuseRinRtheRUSRitRmayRnotRbeRprescribed.
heroin,variousRopiumRderivatives,hallucinogenicRsubstances
ScheduleRIIR-RCORRECTRANSWERR-NoRrefills,RnoRtelephoneRorders
Narcotics,RStimulants,RDepressants
ScheduleRIIIR-RCORRECTRANSWERR-
DrugsRinRthisRcategoryRareRconsideredRtoRbeRatRmoderateRorRlowRriskRforRphysicalRdependence,RandRwithRc
urrentRreasonsRforRmedicalRuse
AnabolicRsteroids,RmostRbarbituatesRandRketamine
MustRprescribeReveryR6Rmonths,RcanRbeRbyRphone
ScheduleRIVR-RCORRECTRANSWERR-
AbuseRpotentialRexists,RbutRlessRthanRSchRIII.RExamplesRare:RAmbien,RDarvocetRandRLorazepam
ScheduleRVR-RCORRECTRANSWERR-NotRalwaysRnecessaryRtoRhaveRaRprescription
Loperamide,RdiphenoxylateRandRcoughRmedicineRwithRlessRthanR200mg/100RmlRpregabalin
, PreclinicalRresearchR-RCORRECTRANSWERR-
ResearchRofRdrugRpotential,RanimalRtesting,RpreparationRforRhumanRtesting
PhaseRIR-RCORRECTRANSWERR-
InitialRclinicalRsafetyRstudiesRinRhumans.RMayRbeRasRfewRasR10Rsubjects,RoftenRhealthyRvolunteers
PhaseRIIR-RCORRECTRANSWERR-TheRstudyRdrugRorRtreatmentRisRgivenRtoRaRlargerRgroupRofRpeopleR(100-
300)RtoRseeRifRitRisReffectiveRandRtoRfurtherRevaluateRitsRsafety
PhaseRIIIR-RCORRECTRANSWERR-TheRstudyRdrugRorRtreatmentRisRgivenRtoRlargeRgroupsRofRpeopleR(1,000-
3,000)RtoRconfirmRitsReffectiveness,RmonitorRsideReffects,RcompareRitRtoRcommonlyRusedRtreatments,RandRc
ollectRinformationRthatRwillRallowRtheRdrugRorRtreatmentRtoRbeRusedRsafely
PhaseRIVR-RCORRECTRANSWERR-
ARstudyRconductedRafterRaRdrugRhasRbeenRshownRtoRworkRandRhasRbeenRgrantedRaRlicenseR(post-
marketingRsurveillanceRstudy)
AdrenergicRagonistsR-RCORRECTRANSWERR-
DrugsRthatRstimulateRandRmimicRtheRactionsRofRtheRsympatheticRnervousRsystem.RAlsoRcalledRsympathomi
metics.
alphaR2RagonistsR-RCORRECTRANSWERR-
DecreaseRsympatheticRimpulsesRfromRtheRCNSRtoRtheRheartRandRarterioles,RcausingRvasodilation
LowersRbloodRpressure,RdiureticRmayRbeRneeded
Clonodine,RMethyldopa,RGuanabenz
SE:RdryRmouth,RurinaryRretention,RweightRgainRetc.
AdrenergicRAntagonistR-RCORRECTRANSWERR-
ARdrugRthatRblocksRtheRactionsRofRtheRsympatheticRnervousRsystem.
AlphaR1RAntagonistR-RCORRECTRANSWERR-DecreasesRarterialRandRvenousRvasoconstriction